Literature DB >> 22388593

Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?

D Lockington1, E C A Macdonald, P Stewart, D Young, M Caslake, K Ramaesh.   

Abstract

INTRODUCTION: Preservatives in ophthalmic preparations are known to cause ocular surface damage. Excipients can also contribute to oxidative stress in the compromised ocular surface. We evaluated commonly used topical glaucoma medications to ascertain pH levels and the intrinsic presence of free radicals.
METHODS: Samples of 27 topical glaucoma preparations were analysed for total free radical presence using a Randox Kit for total antioxidant status. Analytical grade indicator paper was used to ascertain pH levels.
RESULTS: Free radical concentrations for these 27 glaucoma preparations ranged from 0 to 4.54 mmol/l, with a median value of 0.66 mmol/l (mean value of 0.662 mmol/l, SD 0.839). Levels of pH ranged from 4.0 to 7.4, with a median value of 6.5 (mean 6.252, SD 0.826). There was no evidence of a direct correlation between these two variables (r=0.232, P=0.275).
CONCLUSION: This study is the first to document the range of pH and concentrations of free radicals intrinsically present in commonly used glaucoma medications. Long-term exposure to preservatives, free radicals, and pH levels could all contribute to ocular surface damage. The effect of excipients could be responsible for patient intolerance when changing products in the compromised ocular surface.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388593      PMCID: PMC3351058          DOI: 10.1038/eye.2012.25

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

1.  Presence of free radicals in intracameral agents commonly used during cataract surgery.

Authors:  David Lockington; Elisabeth C A Macdonald; David Young; Philip Stewart; Muriel Caslake; Kanna Ramaesh
Journal:  Br J Ophthalmol       Date:  2010-07-19       Impact factor: 4.638

2.  Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.

Authors:  Kazuhide Kawase; Wenzhong Lin; Yumiko Aoyama; Tetsuya Yamamoto; Masamitsu Shimazawa; Hideaki Hara
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

3.  Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.

Authors:  David A Ammar; Robert J Noecker; Malik Y Kahook
Journal:  Adv Ther       Date:  2010-10-07       Impact factor: 3.845

4.  Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.

Authors:  M De Saint Jean; F Brignole; A F Bringuier; A Bauchet; G Feldmann; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-03       Impact factor: 4.799

5.  Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.

Authors:  Masahiko Ayaki; Shigeo Yaguchi; Atsuo Iwasawa; Ryohei Koide
Journal:  Clin Exp Ophthalmol       Date:  2008-08       Impact factor: 4.207

6.  In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Authors:  Christophe Baudouin; Luisa Riancho; Jean-Michel Warnet; Françoise Brignole
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

7.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

8.  Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium.

Authors:  Nancy C Joyce; Cheng C Zhu; Deshea L Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

9.  Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.

Authors:  Hong Liang; Aude Pauly; Luisa Riancho; Christophe Baudouin; Françoise Brignole-Baudouin
Journal:  Br J Ophthalmol       Date:  2011-03-22       Impact factor: 4.638

10.  A patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension.

Authors:  Thomas K Mundorf; Steven H Rauchman; Robert D Williams; Ricardo Notivol
Journal:  Clin Ophthalmol       Date:  2008-09
View more
  7 in total

1.  EDTA chelation for symptomatic band keratopathy: results and recurrence.

Authors:  A Al-Hity; K Ramaesh; D Lockington
Journal:  Eye (Lond)       Date:  2017-12-01       Impact factor: 3.775

2.  Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series.

Authors:  Samantha Bobba; Sharron Chow; Stephanie Watson; Nick Di Girolamo
Journal:  Stem Cell Res Ther       Date:  2015-03-12       Impact factor: 6.832

Review 3.  Preservatives in glaucoma medication.

Authors:  David W Steven; Pouya Alaghband; Kin Sheng Lim
Journal:  Br J Ophthalmol       Date:  2018-07-04       Impact factor: 4.638

4.  Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma.

Authors:  Seoyoung Wy; Young Kook Kim; Jin Wook Jeoung; Ki Ho Park; Ahnul Ha
Journal:  Korean J Ophthalmol       Date:  2020-02

5.  Chemical Cross-Linking of Corneal Tissue to Reduce Progression of Loss of Sight in Patients With Keratoconus.

Authors:  Atikah Haneef; Ramprasad Obula Giridhara Gopalan; Divya T Rajendran; Jessica Nunes; Dharmalingam Kuppamuthu; Naveen Radhakrishnan; Tai-Horng Young; Hao-Ying Hsieh; Namperumalsamy Venkatesh Prajna; Colin E Willoughby; Rachel Williams
Journal:  Transl Vis Sci Technol       Date:  2021-04-29       Impact factor: 3.283

6.  In Vitro Toxicity Evaluation of New Generic Latanost® and Latacom® as an Ophthalmic Formulation.

Authors:  Jessica Sze Chia Ng; Yi Xin Tan; Nor Amalina Ahmad Alwi; Kar Ming Yee; Ahmad Hazri Abdul Rashid; Ka-Liong Tan; Chuei Wuei Leong
Journal:  J Curr Glaucoma Pract       Date:  2021 Sep-Dec

7.  Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma.

Authors:  Barbara Cvenkel; Špela Štunf; Irena Srebotnik Kirbiš; Margareta Strojan Fležar
Journal:  Clin Ophthalmol       Date:  2015-04-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.